| scholarly article | Q13442814 |
| P2093 | author name string | Gerald V Naccarelli | |
| Parag P Patel | |||
| Jay Lin | |||
| Stephen S Johnston | |||
| Kathy L Schulman | |||
| P2860 | cites work | A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. | Q55036185 |
| Impact of varicella vaccination on health care utilization. | Q55041153 | ||
| Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation | Q57809200 | ||
| Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials | Q72030226 | ||
| The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study | Q72198409 | ||
| Risk of stroke in patients with atrial flutter | Q73412509 | ||
| Cost of care distribution in atrial fibrillation patients: the COCAF study | Q75202014 | ||
| Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience | Q81684556 | ||
| Effect of dronedarone on cardiovascular events in atrial fibrillation | Q28235128 | ||
| Increased mortality after dronedarone therapy for severe heart failure | Q28284464 | ||
| Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q28303699 | ||
| Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group | Q28372836 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study | Q29614197 | ||
| A chronic disease score from automated pharmacy data | Q30983653 | ||
| Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. | Q31085984 | ||
| Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials | Q33239538 | ||
| Current trends in heart failure readmission rates: analysis of Medicare data. | Q33399817 | ||
| A comparison of rate control and rhythm control in patients with atrial fibrillation | Q34162727 | ||
| Rising rates of hospital admissions for atrial fibrillation. | Q34271333 | ||
| Treatment charges and resource use among patients with heart failure enrolled in an MCO. | Q34651168 | ||
| Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. | Q36015557 | ||
| Initiation of statins after hospitalization for coronary heart disease | Q36867240 | ||
| Incidence, comorbidity, case fatality and readmission of hospitalized stroke patients in Canada | Q36883340 | ||
| Changing trends of hospital utilization in patients after their first episode of atrial fibrillation | Q37094834 | ||
| The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study | Q39791686 | ||
| Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence | Q40310174 | ||
| Impact of atrial fibrillation on mortality, stroke, and medical costs | Q44057872 | ||
| Increasing prevalence of atrial fibrillation and flutter in the United States | Q44353676 | ||
| Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study | Q44790546 | ||
| Population rates of hospitalization for atrial fibrillation/flutter in Canada. | Q44987798 | ||
| Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation | Q46887352 | ||
| The natural history of lone atrial flutter | Q47200124 | ||
| Resource utilization and costs of stroke unit care integrated in a care continuum: A 1-year controlled, prospective, randomized study in elderly patients: the Göteborg 70+ Stroke Study | Q50667020 | ||
| Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. | Q50723295 | ||
| Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. | Q50788630 | ||
| ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog | Q51935524 | ||
| Death and readmission in the year after hospital admission with cardiovascular disease: the Hunter Area Heart and Stroke Register. | Q53768037 | ||
| P433 | issue | 5 | |
| P921 | main subject | circulatory system | Q11068 |
| Atrial Fibrillation | Q815819 | ||
| hospitalization | Q3140971 | ||
| P304 | page(s) | 270-279 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Clinical Cardiology | Q4502312 |
| P1476 | title | Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States | |
| P478 | volume | 33 |
| Q30886141 | A common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical records |
| Q40979000 | CHADS2 and CHA2DS2-VASc scores are independently associated with incident atrial fibrillation: the Catanzaro Atrial Fibrillation Project. |
| Q35790082 | Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses. |
| Q35832134 | Cost considerations in the management of atrial fibrillation - impact of dronedarone |
| Q38084943 | Cost effectiveness of antiarrhythmic medications in patients suffering from atrial fibrillation |
| Q36382393 | Cost of atrial fibrillation: invasive vs non-invasive management in 2012 |
| Q35885128 | Costs and clinical consequences of suboptimal atrial fibrillation management |
| Q42197777 | Economic Modeling of Heart Failure Telehealth Programs: When Do They Become Cost Saving? |
| Q39109136 | Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin |
| Q51167538 | Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation. |
| Q37653118 | Impact of dronedarone treatment on healthcare resource utilization in patients with atrial fibrillation/flutter |
| Q46306071 | Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors |
| Q36168690 | Individual and Combined Risk Factors for Incident Atrial Fibrillation and Incident Stroke: An Analysis of 3 Million At-Risk US Patients |
| Q28076912 | Patient-level costs of major cardiovascular conditions: a review of the international literature |
| Q39780721 | Post-ATHENA and beyond |
| Q35135665 | Predictors of long-term clinical endpoints in patients with refractory angina |
| Q35440513 | Safety and efficacy of dronedarone in the treatment of atrial fibrillation/flutter |
| Q41839628 | Short-term ECG recordings for heart rate assessment in patients with chronic atrial fibrillation |
| Q37523118 | Systematic review and meta-analysis of surgical ablation for atrial fibrillation during mitral valve surgery |
| Q37968514 | The management of patients with atrial fibrillation and dronedarone's place in therapy |
Search more.